Teva Pharmaceuticals USA, Inc. et al v. MYLAN Pharmaceuticals Inc. et al
| Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd. and TEVA Neuroscience, Inc. |
| MYLAN Pharmaceuticals Inc., MYLAN Inc. and Natco Pharma Ltd. |
| 1:2010cv07246 |
| September 20, 2010 |
| US District Court for the Southern District of New York |
| Foley Square Office |
| XX Out of State |
| Katherine B Forrest |
| Patent |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 28, 2017. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 88 SEALED MATERIALS DISPOSED: Document(s) 65 were destroyed since the filing party did not retrieve the material(s) within 30 days of the date indicated. The sealed record(s) were destroyed on 11/28/2017.(mps) |
| Filing 87 NOTICE TO ATTORNEY TO RETRIEVE SEALED MATERIAL: Notice to the attorney of record for the filing party to retrieve sealed document number 65 within thirty (30) days, or the Court will dispose of them. Sealed Records Retrieval due by 11/24/2017. (mps) |
| Appeal Fee Refunded: for #83 Notice of Appeal,,. Filing fee refunded for Receipt number 0208-8797466, for the following reason(s): INCORRECT FILING. (dig) |
| Filing 86 MANDATE of USCA FOR THE FEDERAL CIRCUIT (Certified Copy) as to #84 Notice of Appeal to the Federal Circuit, filed by Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc., Teva Pharmaceuticals USA, Inc. USCA Case Number 13-1573. It is hereby ORDERED that the proceeding is DISMISSED pursuant to Rule 42(b) of the Federal Rules of Appellate Procedure. Jan Horbaly, Clerk USCA for the Federal Circuit. Issued As Mandate: 9/5/2013. (nd) |
| Filing 85 NOTICE OF DOCKETING from U.S. Court of Appeals for the Federal Circuit: USCA Case Number 13-1573 from the US Court of Appeals, Federal Circuit assigned to #84 Notice of Appeal to the Federal Circuit, filed by Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc., Teva Pharmaceuticals USA, Inc.. (nd) |
| Transmission of Notice of Appeal and Certified Copy of Docket Sheet to US Court of Appeals for the Federal Circuit, re: #84 Notice of Appeal to the Federal Circuit. (nd) |
| Filing 84 NOTICE OF APPEAL TO THE FEDERAL CIRCUIT from #81 Clerk's Judgment, #80 Memorandum & Opinion,,. Form 7 and Form 22 are due within 14 days. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. Filing fee $ 455.00, receipt number 0208-8797624. (Hashmall, David) |
| Filing 83 FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU - NOTICE OF APPEAL from #81 Clerk's Judgment, #80 Memorandum & Opinion,,. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. Filing fee $ 455.00, receipt number 0208-8797466. Form C and Form D are due within 14 days to the Court of Appeals, Second Circuit. (Hashmall, David) Modified on 8/20/2013 (nd). |
Filing 82
ENDORSED LETTER addressed to Judge Katherine B. Forrest from Shannon M. Bloodworth dated 7/31/13 re: Counsel requests that the Court order that any application for attorney fees under Rule 54 be due by 8/16/13. ENDORSEMENT: Ordered: Application granted. (Signed by Judge Katherine B. Forrest on 8/1/2013) (mro) Modified on 8/1/2013 (mro).
|
| Set/Reset Deadlines: Motions due by 8/16/2013. (mro) |
| Filing 81 CLERK'S JUDGMENT; That for the reasons stated in the Court's Opinion and Order dated July 15, 2013, the motions to dismiss brought by defendants Mylan, Natco, and Sandoz are granted in their entirety and these actions 09 Civ. 10112 and 10 Civ. 7246 are terminated. (Signed by Clerk of Court Ruby Krajick on 7/19/2013) (Attachments: #1 Notice of Right to Appeal)(dt) |
|
Filing 80
OPINION & ORDER re: (81 in 1:09-cv-10112-KBF) MOTION to Dismiss filed by Momenta Pharmaceuticals, Inc., Sandoz Inc., (58 in 1:10-cv-07246-KBF) MOTION to Dismiss filed by Natco Pharma Ltd., (60 in 1:10-cv-07246-KBF) MOTION to Dismiss filed by MYLAN Pharmaceuticals Inc., MYLAN Inc. For all of the reasons set forth above, the motions to dismiss brought by defendants Mylan, Natco, and Sandoz are granted in their entirety. The Clerk of Court is directed to terminate the motions at 09 Civ. 10112 (ECF No. 81), and 10 Civ. 7246 (ECF Nos. 58 and 60), and to terminate these actions. (Signed by Judge Katherine B. Forrest on 7/15/2013) (mro)
|
| Transmission to Judgments and Orders Clerk. Transmitted re: #80 Memorandum & Opinion, to the Judgments and Orders Clerk. (mro) |
|
Filing 79
MEMO ENDORSEMENT on #50 NOTICE OF WITHDRAWAL OF COUNSEL filed by Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc., Teva Pharmaceuticals USA, Inc. Plaintiffs provide notice that Carolyn A. Blessing is no longer an associate with Kenyon & Kenyon LLP and respectfully request that she be removed from the Court's docket and Electronic Case Filing system. ENDORSEMENT: So ordered. (Signed by Judge Katherine B. Forrest on 7/15/2013) (mro)
|
|
Filing 78
ENDORSED LETTER addressed to Judge Katherine B. Forrest from David L. Anstaett dated 6/25/13 re: Counsel writes on behalf of defendants Mylan Pharmaceuticals Inc., Mylan Inc., and Natco Pharma Ltd., to inform the Court that yesterday the United States Supreme Court denied certiorari in Momenta Pharms., Inc. v. Amphastar Pharms., Inc., 686 F.3d 1348 (Fed. Cir. 2012). ENDORSEMENT: Ordered: Post on docket. (Signed by Judge Katherine B. Forrest on 6/27/2013) (mro)
|
|
Filing 77
ORDER ADMITTING COUNSEL PRO HAC VICE: granting #76 Motion for Nicholas K. Mitrokostas to Appear Pro Hac Vice. ORDERED that, pursuant to Local Civil Rule 1.3(c) of the Local Rules of this Court, Nicholas K. Mitrokostas, is hereby admitted pro hac vice to the bar of this Court for the purpose of representing Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Industries Ltd., and Teva Neuroscience, Inc. in the above-captioned proceeding.(Signed by Judge Katherine B. Forrest on 5/28/2013) (ama)
|
| Filing 76 MOTION for Nicholas K. Mitrokostas to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8543113. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Proposed Order)(Mitrokostas, Nicholas) |
| >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #76 MOTION for Nicholas K. Mitrokostas to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8543113. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
|
Filing 75
ENDORSED LETTER addressed to Judge Katherine B. Forrest from Henry C. Dinger dated 5/20/2013 re: Counsel submits this letter in response to the Court's May 13 order that the parties submit a letter brief on the applicability of 35 U.S.C. 271(e)(1) to the defendants' use of Teva's patented marker technology after FDA approval of their ANDAs in light of Momenta Pharms., Inc. v. Amphastar Pharms., Inc. 686 F.3d 1348 (Fed. Cir. 2012), cert. petition pending. ENDORSEMENT: ORDERED. Post to docket. (Signed by Judge Katherine B. Forrest on 5/21/2013) (tro)
|
|
Filing 74
ENDORSED LETTER addressed to Judge Katherine B. Forrest from David L. Anstaett dated 5/20/2013 re: Mylan requests that the Court grant defendants' motions to dismiss in their entirety. ENDORSEMENT: ORDERED. Post on Docket. (Signed by Judge Katherine B. Forrest on 5/21/2013) (tro)
|
|
Filing 73
ENDORSED LETTER addressed to Judge Katherine B. Forrest from David L. Anstaett dated 5/17/13 re: Counsel writes in response to the Court's order of May 14, 2013 and makes the representations herein. ENDORSEMENT: Ordered: Post on docket. (Signed by Judge Katherine B. Forrest on 5/20/2013) (mro)
|
|
Filing 72
ORDER: As discussed at the oral argument on the pending motions to dismiss in this action held on May 13, 2013: 1. Any party who desires may submit a five-page, single-spaced letter brief on defendants' conduct during the commercialization period, especially in light of the Federal Circuit's decision in Momenta Pharms., Inc. v. Amphastar Pharms., Inc., 686 F.3d 1348 (Fed. Cir. 2012). These letters shall be submitted to the Court via email not later than 6:00 p.m. on Monday, May 20, 2013; and 2. Defendants MYLAN Pharmaceuticals Inc., MYLAN Inc., and Natco Pharma Ltd. shall also report to the Court by letter whether those defendants consent to the same "representations" as made by defendants Sandoz Inc., and Momenta Pharmaceuticals, Inc. at during the oral argument. (Signed by Judge Katherine B. Forrest on 5/14/2013) (mro)
|
| Minute Entry for proceedings held before Judge Katherine B. Forrest: Oral Argument held on 5/13/2013. (jp) |
|
Filing 71
ORDER: The oral argument on the motions to dismiss in these actions currently scheduled for Friday, May 3, 2013, is hereby rescheduled for Monday, May 13, 2013, at 2:00 p.m. ( Oral Argument set for 5/13/2013 at 02:00 PM before Judge Katherine B. Forrest.) (Signed by Judge Katherine B. Forrest on 4/26/2013) (mt)
|
|
Filing 70
ORDER ADMITTING COUNSEL PRO HAC VICE granting #69 Motion for Henry C. Dinger to Appear Pro Hac Vice. It is hereby ORDERED that, pursuant to Local Civil Rule 1.3(c) of the Local Rules of this Court, Henry C. Dinger, is hereby admitted pro hac vice to the bar of this Court for the purpose of representing Plaintiffs Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., and Teva Neuroscience, Inc. in the above-captioned proceeding. (Signed by Judge Katherine B. Forrest on 4/22/2013) (mro)
|
| >>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #69 MOTION for Henry C. Dinger to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8433973. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
| Filing 69 MOTION for Henry C. Dinger to Appear Pro Hac Vice. Filing fee $ 200.00, receipt number 0208-8433973. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Proposed Order)(Dinger, Henry) |
| Filing 68 REPLY MEMORANDUM OF LAW in Support re: #58 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Bloodworth, Shannon) |
| Filing 67 DECLARATION of David L. Anstaett in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1)(Bloodworth, Shannon) |
| Filing 66 REPLY MEMORANDUM OF LAW in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Bloodworth, Shannon) |
| Filing 65 SEALED DOCUMENT placed in vault.(nm) |
| Filing 64 NOTICE of Materials Filed Under Seal. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
| Filing 63 MEMORANDUM OF LAW in Opposition re: #58 MOTION to Dismiss.. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
| Filing 62 DECLARATION of David L. Anstaett in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit Exhibit 1, #2 Exhibit Exhibit 2, #3 Exhibit Exhibit 3, #4 Exhibit Exhibit 4, #5 Exhibit Exhibit 5, #6 Exhibit Exhibit 6, #7 Exhibit Exhibit 7)(Bloodworth, Shannon) |
| Filing 61 MEMORANDUM OF LAW in Support re: #60 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Bloodworth, Shannon) |
| Filing 60 MOTION to Dismiss. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. Responses due by 4/5/2013 Return Date set for 4/17/2013 at 11:59 PM.(Bloodworth, Shannon) |
| Filing 59 MEMORANDUM OF LAW in Support re: #58 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Bloodworth, Shannon) |
| Filing 58 MOTION to Dismiss. Document filed by Natco Pharma Ltd.. Responses due by 4/5/2013 Return Date set for 4/17/2013 at 11:59 PM.(Bloodworth, Shannon) |
|
Filing 57
ORDER: that the Court-ordered stays at 09 Civ. 10112, docket no. 71 and at 10 Civ. 7246 docket no. 48 are hereby vacated; and IT IS FURTHER ORDERED that the motion to dismiss at 09 Civ. 10112, docket no. 46, is denied as moot; IT IS FURTHER ORDERED that any party who desires may file a new motion to dismiss no later than March 8, 2013, with opposition papers due no later than April 5, 2013, and reply papers, if any, due by April 17, 2013. The Court will hold oral argument on any motions to dismiss so filed on Friday, May 3, 2013, at 2:00 p.m. The Clerk of the Court is directed to terminate the motion at 09 Civ. 10112, docket no. 46. ( Motions due by 3/8/2013, Responses due by 4/5/2013, Replies due by 4/17/2013.) ( Oral Argument set for 5/3/2013 at 02:00 PM before Judge Katherine B. Forrest.) (Signed by Judge Katherine B. Forrest on 1/28/2013) (ja)
|
|
Filing 56
ORDER: The Court issues this order to clarify its January 15, 2013 letter endorsement and to request additional information from the parties. The parties are hereby ORDERED to provide the Court with the letter and documents as set forth herein. The parties shall confer amongst themselves so that only one copy of each document is provided to the Court. The parties shall provide these documents stapled or in spiral binding--no velobinding please. The parties shall provide the requested letter and documents by January 28, 2013. (Signed by Judge Katherine B. Forrest on 1/23/2013) (djc)
|
|
Filing 55
ENDORSED LETTER addressed to Judge Katherine B. Forrest from Elizabeth J. Holland dated 1/14/2013 re: We write on behalf of the parties in response to the January 10,2013 Order directing the parties to resubmit the correspondence ordered by the Court on October 10,2012. ENDORSEMENT: The parties are to submit any and all papers in support of, or in opposition to, any motion to dismiss, not later than C.O.B. 1/18/13. (No velo binding of the memos of law please--spiral or staple). (Signed by Judge Katherine B. Forrest on 1/15/2013) (cd)
|
|
Filing 54
ORDER: ORDERED that no later than January 14, 2013, the parties are to resubmit the correspondence ordered by the Court's October 10, 2012, Order (ECF No. 74). The parties may submit all correspondence exchanged pursuant to the October 10 Order via email at ForrestNYSDChambers@nysd.uscourts.gov.IT IS FURTHER ORDERED that no later than January 17, 2013, the parties are to provide a letter to the Court (preferably a joint letter) summarizing the procedural history of these actions as well as the status of all actions. The joint letter may also be submitted via email at the above-listed email address. (Signed by Judge Katherine B. Forrest on 1/10/2013) (djc) Modified on 1/10/2013 (djc).
|
| Filing 53 NOTICE OF CASE REASSIGNMENT to Judge Katherine B. Forrest. Judge Barbara S. Jones is no longer assigned to the case. (pgu) |
|
Filing 52
ORDER: The parties are directed to confer and advise the Court in writing of their positions regarding whether these cases should remain stayed on or before October 17, 2012. (Signed by Judge Barbara S. Jones on 10/10/2012) (pl)
|
|
Filing 51
ENDORSED LETTER addressed to Judge Barbara S. Jones from Shannon M. Bloodworth dated 6/7/2012 re: Counsel requests that Alfonso N. Cornish, II be removed from the docket sheets and all service lists and no longer receive electronic notifications in these actions. ENDORSEMENT: SO ORDERED. (Signed by Judge Barbara S. Jones on 6/8/2012) (tro)
|
| Filing 50 NOTICE of WITHDRAWAL OF COUNSEL. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Jean, Patrice) |
|
Filing 49
ORDER: For the reasons stated on the record during the November 3,2011 conference call, the stay in both of these cases will remain in place until December 15, 2011. (Signed by Judge Barbara S. Jones on 11/7/2011) (cd)
|
| CASE NO LONGER REFERRED to Magistrate Judge Andrew J. Peck. I have closed the above reference for magistrate judge statistical purposes. Reason: Return to D.J. (Case Stayed). (jab) |
|
Filing 48
STIPULATION AND ORDER: lT IS HEREBY STIPULATED AND AGREED by and between the parties, through their undersigned counsel as follows: 1. The schedule set forth in the Scheduling Order (D.I. 15) is hereby stayed until November 1, 2011. The parties will submit a proposed discovery schedule to the Court by November 1, 2011, should the case remain pending at that time. 2. Nothing in this Stipulation prevents Plaintiffs from seeking injunctive relief against Defendants or from moving to have the stay lifted in the event of a change of circumstance. 3. Nothing in this Stipulation precludes the Court from ruling on Defendants' motions to dismiss. (Signed by Judge Barbara S. Jones on 5/23/2011) (ja)
|
| Filing 47 AMENDED CLAIM CONSTRUCTION STATEMENT. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd., TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd..(Hassett, Annemarie) |
| Filing 46 JOINT STIPULATION that the deadline to file and serve the parties' opening claim construction briefs and supporting materials is extended to 5/20/11. Expert depositions may be held between 6/17 and 7/15/11, and as further set forth in this document. (Signed by Magistrate Judge Andrew J. Peck on 5/10/11) (cd) |
| Filing 45 JOINT CLAIM CONSTRUCTION STATEMENT. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc., TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd..(Hassett, Annemarie) |
| Filing 44 NOTICE OF APPEARANCE by Annemarie Hassett on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Hassett, Annemarie) |
| Filing 43 ENDORSED LETTER addressed to Magistrate Judge Andrew J. Peck from John T. Bennett dated 3/31/2011 re: Counsel writes to request that the Court quash the subpoena served upon Dr. Johnson and limit the scope of another third party subpoena served upon W.R. Grace & Co. ENDORSEMENT: 1. The Court will allow the Court whose subpoenas are at issue, the District of Maryland, to rule on the scope of the subpoenas. 2. However, to remove any incentive on the parties to use the deposition testimony or documents (and ESI) for purposes of the 09 Civ. 8824 case, this Court now rules that nothing learned from the depositions or documents can be used in 09 Civ. 8824. If after the D.Md. court rules, there is any other issue for this Court, either side may raise it with this Court. (Signed by Magistrate Judge Andrew J. Peck on 4/1/2011) (tro) Modified on 4/4/2011 (tro). |
|
Filing 42
ENDORSED LETTER addressed to Judge Barbara S. Jones from Nicholas Groombridge dated 2/17/2011 re: Counsel respectfully request that Patricia Young be permitted to withdraw as counsel of record in this matter and be removed from the ECF service list. ENDORSEMENT: Application granted. So Ordered. (Signed by Judge Barbara S. Jones on 2/28/2011) (jfe)
|
|
Filing 41
ORDER ADMITTING COUNSEL PRO HAC VICE: granting #40 Motion for Daryl L. Wiesen to Appear Pro Hac Vice. (Signed by Judge Barbara S. Jones on 1/18/11) (laq)
|
| CASHIERS OFFICE REMARK on #40 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 01/18/2011, Receipt Number 925845. (jd) |
| CASHIERS OFFICE REMARK on 40 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 01/18/2011, Receipt Number 925845. (jd) |
| Filing 40 MOTION for Daryl L. Wiesen to Appear Pro Hac Vice. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(mbe) |
|
Filing 39
ENDORSED LETTER addressed to Magistrate Judge Andrew J. Peck from John T. Bennett and Shannon Bloodworth, dated 1/11/2011, re: Counsel in the above-referenced case have conferred and determined that there are no issues ripe for submission to the Court at this time. Both parties therefore, request cancellation of the status conference scheduled for tomorrow at 2:00 p.m. The parties will submit a written request for a hearing before Your Honor should the need arise in the coming weeks. ENDORSEMENT: SO ORDERED. (Signed by Magistrate Judge Andrew J. Peck on 1/11/11) Copies Faxed By Chambers. (lnl)
|
| Filing 38 REPLY MEMORANDUM OF LAW in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Solano, Ricardo) |
| Filing 37 DECLARATION of Ricardo Solano Jr. in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1)(Solano, Ricardo) |
| Filing 36 REPLY MEMORANDUM OF LAW in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Solano, Ricardo) |
|
Filing 35
ENDORSED LETTER addressed to Judge Barbara S. Jones from Andrew Levine dated 12/30/2010 re: Requesting that my name be removed from the docket sheets and all service lists and that I no longer receive electronic notifications in the above actions. ENDORSEMENT: So Ordered. (Signed by Judge Barbara S. Jones on 1/3/2011) (jpo)
|
| CASHIERS OFFICE REMARK on 28 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 12/15/2010, Receipt Number 923641. (jd) |
| CASHIERS OFFICE REMARK on #28 Motion to Appear Pro Hac Vice in the amount of $25.00, paid on 12/15/2010, Receipt Number 923641. (jd) |
| Filing 34 SEALED DOCUMENT placed in vault.(nm) |
| Filing 33 DECLARATION of Joseph B. Crystal in Support of Plaintiffs' Memorandum of Law in Opposition to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc.'s Motion to Dismiss (FILED UNDER SEAL). Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Hashmall, David) |
| Filing 32 MEMORANDUM OF LAW in Opposition re: #25 MOTION to Dismiss.. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
| Filing 31 NOTICE of Materials Filed Under Seal. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd.. (Hashmall, David) |
|
Filing 30
ORDER ADMITTING COUNSEL PRO HAC VICE: It is hereby ordered that John T. Bennett is admitted pro hac vice in this action. (Signed by Judge Barbara S. Jones on 12/22/2010) (jpo)
|
| Filing 29 NOTICE OF APPEARANCE by Joseph B. Crystal on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Crystal, Joseph) |
| Filing 28 MOTION for John T. Bennett to Appear Pro Hac Vice. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(mbe) |
| CASHIERS OFFICE REMARK on #16 Order Admitting Attorney Pro Hac Vice, in the amount of $175.00, paid on 11/16/2010, Receipt Number 921466. (jd) |
| CASHIERS OFFICE REMARK on 16 Order Admitting Attorney Pro Hac Vice, in the amount of $175.00, paid on 11/16/2010, Receipt Number 921466. (jd) |
| Filing 27 DECLARATION of Ricardo Solano Jr. in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Solano, Ricardo) |
| Filing 26 MEMORANDUM OF LAW in Support re: #25 MOTION to Dismiss.. Document filed by Natco Pharma Ltd.. (Solano, Ricardo) |
| Filing 25 MOTION to Dismiss. Document filed by Natco Pharma Ltd..(Solano, Ricardo) |
| Filing 24 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Natco Pharma Ltd..(Solano, Ricardo) |
| Filing 23 DECLARATION of Ricardo Solano Jr. in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Solano, Ricardo) |
| Filing 22 MEMORANDUM OF LAW in Support re: #21 MOTION to Dismiss.. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc.. (Solano, Ricardo) |
| Filing 21 MOTION to Dismiss. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc..(Solano, Ricardo) |
| Filing 20 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by MYLAN Inc., MYLAN Pharmaceuticals Inc..(Solano, Ricardo) |
|
Filing 19
STIPULATION AND AND PROPOSED SEALING ORDER: It is hereby stipulated and agreed by and between the parties that the Defendants' motions to dismiss and supporting evidence shall be sealed and treated in accordance with the Stipulated Protective Order entered in the ANDA litigation (Docket No. 54) pending entry of a protective order in the present case, and any oppositions or replies to the motions to dismiss and any related motions and briefing (including motions to stay based on the motion to dismiss) may similarly be filed under seal and will be treated in accordance with the Stipulated Protective Order entered in the ANDA litigation. (Signed by Judge Barbara S. Jones on 12/4/2010) (jpo)
|
| Transmission to Sealed Records Clerk. Transmitted re: 19 Stipulation and Order, Set Deadlines/Hearings, to the Sealed Records Clerk for the sealing or unsealing of document or case. (jpo) |
| Transmission to Sealed Records Clerk. Transmitted re: #19 Stipulation and Order, Set Deadlines/Hearings, to the Sealed Records Clerk for the sealing or unsealing of document or case. (jpo) |
| Filing 18 TRANSCRIPT of proceedings held on November 4, 2010 at 10:00 a.m. before Magistrate Judge Andrew J. Peck. (js) |
| Filing 17 TRANSCRIPT of proceedings held on November 4, 2010 10:00 a.m. before Magistrate Judge Andrew J. Peck. (ajc) |
|
Filing 16
ORDER FOR ADMISSION PRO HAC VICE: It is hereby Ordered that Attorneys John Singleton Skilton, Alfonso Nathaniel Cornish, II, David L. Anstaett, Sarah C. Wolkenhorst, Shannon M Bloodworth, Brandon Michael White and Colin Gene Sandercock for MYLAN Inc., MYLAN Pharmaceuticals Inc., and Natco Pharma Ltd. admitted Pro Hac Vice. (Signed by Judge Barbara S. Jones on 11/12/2010) (jfe)
|
|
Filing 15
JOINT STIPULATION AND SCHEDULING ORDER: Brief due by 5/14/2011., Discovery due by 10/28/2011. Responses due by 6/17/2011, Replies due by 7/15/2011. Status Conference set for 1/12/2011 at 02:00 PM before Magistrate Judge Andrew J. Peck. (Signed by Magistrate Judge Andrew J. Peck on 11/10/2010) (jpo)
|
| Minute Entry for proceedings held before Magistrate Judge Andrew J. Peck: Scheduling Conference held on 11/4/2010, ( Discovery (Fact) due by 6/1/2011 and Discovery (Expert) due by 10/28/2011., Status Conference set for 1/12/2011 at 02:00 PM before Magistrate Judge Andrew J. Peck.). (mbe) |
| Filing 14 NOTICE OF APPEARANCE by Andrew Levine on behalf of MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd. (Levine, Andrew) |
| Filing 13 NOTICE OF APPEARANCE by Ricardo Solano, Jr on behalf of MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd. (Solano, Ricardo) |
| Filing 12 NOTICE OF APPEARANCE by Carolyn Anne Blessing on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Blessing, Carolyn) |
| Filing 11 NOTICE OF APPEARANCE by Patrice Polyxene Jean on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Jean, Patrice) |
| Filing 10 NOTICE OF APPEARANCE by William G. James, II on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (James, William) |
| Filing 9 NOTICE OF APPEARANCE by Elizabeth J. Holland on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Holland, Elizabeth) |
| Filing 8 NOTICE OF APPEARANCE by Steven Jeffrey Lee on behalf of TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co. Ltd. (Lee, Steven) |
|
Filing 7
JOINT STIPULATION AND ORDER, by and between the parties, through their undersigned counsel that Defendants have accepted service of the complaint and waive any right to dispute the validity of such service and the deadline to answer, move or otherwise respond to the complaint is December 6, 2010. MYLAN Inc. answer due 12/6/2010; MYLAN Pharmaceuticals Inc. answer due 12/6/2010; Natco Pharma Ltd. answer due 12/6/2010. (Signed by Judge Barbara S. Jones on 10/2/2010) (lnl)
|
|
Filing 6
ORDER SCHEDULING INITIAL PRETRIAL CONFERENCE: Initial Conference set for 11/4/2010 at 10:00 AM in Courtroom 20D, 500 Pearl Street, New York, NY 10007 before Magistrate Judge Andrew J. Peck. (Signed by Magistrate Judge Andrew J. Peck on 10/29/2010) (jfe)
|
|
Filing 5
ORDER REFERRING CASE TO MAGISTRATE JUDGE. Order that case be referred to the Clerk of Court for assignment to a Magistrate Judge for General Pretrial (includes scheduling, discovery, non-dispositive pretrial motions, and settlement). Referred to Magistrate Judge Andrew J. Peck. (Signed by Judge Barbara S. Jones on 10/22/2010) (jpo)
|
| Filing 4 NOTICE OF CASE ASSIGNMENT to Judge Barbara S. Jones. Judge Unassigned is no longer assigned to the case. (ldi) |
| Magistrate Judge Andrew J. Peck is so designated. (ldi) |
| CASE ACCEPTED AS RELATED. Create association to 1:09-cv-10112-BSJ. Notice of Assignment to follow. (ldi) |
| Filing 3 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Yeda Trust as Corporate Parent. Document filed by Yeda Research and Development Co. Ltd..(rdz) (ama). |
| Filing 2 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Orvet UK Unlimited, Teva Pharmaceuticals Holdings Cooperative U.A.. Ivax LLC fka IVAX Corporation, Teva Pharmaceuticals Europe, B.V., Teva Pharmaceuticals Ltd.Teva Pharmaceuticals USA, Inc. as Corporate Parent. Document filed by TEVA Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc..(rdz) (ama). |
| Filing 1 COMPLAINT against MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (Filing Fee $ 350.00, Receipt Number 915557)Document filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc..(rdz) Modified on 9/23/2010 (rdz). (Additional attachment(s) added on 11/5/2010: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D) (ama). |
| Filing 1 COMPLAINT against MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (Filing Fee $ 350.00, Receipt Number 915557)Document filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Yeda Research and Development Co. Ltd., TEVA Neuroscience, Inc..(rdz) Modified on 9/23/2010 (rdz). (Additional attachment(s) added on 11/5/2010: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D) (ama). |
| SUMMONS ISSUED as to MYLAN Inc., MYLAN Pharmaceuticals Inc., Natco Pharma Ltd.. (rdz) |
| Case Designated ECF. (rdz) |
| Mailed notice to Commissioner of Patents and Trademarks to report the filing of this action. (rdz) |
| CASE REFERRED TO Judge Barbara S. Jones as possibly related to 09-cv-10112. (rdz) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
